vs
卡骆驰（CROX）与Healthpeak Properties（DOC）财务数据对比。点击上方公司名可切换其他公司
卡骆驰的季度营收约是Healthpeak Properties的1.3倍（$957.6M vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 11.0%，领先62.2%），Healthpeak Properties同比增速更快（3.1% vs -3.2%），Healthpeak Properties自由现金流更多（$357.0M vs $246.4M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 1.0%）
卡骆驰（Crocs）是总部位于美国科罗拉多州布鲁姆菲尔德的鞋履企业，主打生产、销售旗下同名品牌的泡沫鞋履产品。其标志性鞋款虽被品牌称为“木屐”，但和传统木屐不同，不含木质材料，凭借舒适轻便的特性受到全球消费者喜爱。
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
CROX vs DOC — 直观对比
营收规模更大
CROX
是对方的1.3倍
$719.4M
营收增速更快
DOC
高出6.3%
-3.2%
净利率更高
DOC
高出62.2%
11.0%
自由现金流更多
DOC
多$110.6M
$246.4M
两年增速更快
DOC
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $957.6M | $719.4M |
| 净利润 | $105.2M | $114.0M |
| 毛利率 | 54.7% | — |
| 营业利润率 | 15.3% | 17.4% |
| 净利率 | 11.0% | 73.2% |
| 营收同比 | -3.2% | 3.1% |
| 净利润同比 | -71.5% | 2406.4% |
| 每股收益（稀释后） | $1.79 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CROXDOC
| Q4 25 | $957.6M | $719.4M | ||
| Q3 25 | $996.3M | $705.9M | ||
| Q2 25 | $1.1B | $694.3M | ||
| Q1 25 | $937.3M | $702.9M | ||
| Q4 24 | $989.8M | $698.0M | ||
| Q3 24 | $1.1B | $700.4M | ||
| Q2 24 | $1.1B | $695.5M | ||
| Q1 24 | $938.6M | $606.6M |
净利润CROXDOC
| Q4 25 | $105.2M | $114.0M | ||
| Q3 25 | $145.8M | $-117.1M | ||
| Q2 25 | $-492.3M | $31.7M | ||
| Q1 25 | $160.1M | $42.8M | ||
| Q4 24 | $368.9M | $4.5M | ||
| Q3 24 | $199.8M | $85.9M | ||
| Q2 24 | $228.9M | $146.0M | ||
| Q1 24 | $152.5M | $6.7M |
毛利率CROXDOC
| Q4 25 | 54.7% | — | ||
| Q3 25 | 58.5% | 58.6% | ||
| Q2 25 | 61.7% | 60.2% | ||
| Q1 25 | 57.8% | 61.1% | ||
| Q4 24 | 57.9% | 60.3% | ||
| Q3 24 | 59.6% | 60.0% | ||
| Q2 24 | 61.4% | 60.6% | ||
| Q1 24 | 55.6% | 59.8% |
营业利润率CROXDOC
| Q4 25 | 15.3% | 17.4% | ||
| Q3 25 | 20.8% | 9.2% | ||
| Q2 25 | -37.2% | 5.7% | ||
| Q1 25 | 23.8% | 7.7% | ||
| Q4 24 | 20.2% | -2.2% | ||
| Q3 24 | 25.4% | 14.1% | ||
| Q2 24 | 29.3% | 22.3% | ||
| Q1 24 | 24.1% | 3.7% |
净利率CROXDOC
| Q4 25 | 11.0% | 73.2% | ||
| Q3 25 | 14.6% | -16.6% | ||
| Q2 25 | -42.8% | 4.6% | ||
| Q1 25 | 17.1% | 6.1% | ||
| Q4 24 | 37.3% | 0.7% | ||
| Q3 24 | 18.8% | 12.3% | ||
| Q2 24 | 20.6% | 21.0% | ||
| Q1 24 | 16.2% | 1.1% |
每股收益（稀释后）CROXDOC
| Q4 25 | $1.79 | $0.16 | ||
| Q3 25 | $2.70 | $-0.17 | ||
| Q2 25 | $-8.82 | $0.05 | ||
| Q1 25 | $2.83 | $0.06 | ||
| Q4 24 | $6.25 | $0.02 | ||
| Q3 24 | $3.36 | $0.12 | ||
| Q2 24 | $3.77 | $0.21 | ||
| Q1 24 | $2.50 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $130.4M | $467.5M |
| 总债务越低越好 | — | $9.8B |
| 股东权益账面价值 | $1.3B | $7.5B |
| 总资产 | $4.2B | $20.3B |
| 负债/权益比越低杠杆越低 | — | 1.31× |
8季度趋势，按日历期对齐
现金及短期投资CROXDOC
| Q4 25 | $130.4M | $467.5M | ||
| Q3 25 | $154.0M | $91.0M | ||
| Q2 25 | $200.6M | $89.4M | ||
| Q1 25 | $166.5M | $70.6M | ||
| Q4 24 | $180.5M | $119.8M | ||
| Q3 24 | $186.1M | $180.4M | ||
| Q2 24 | $167.7M | $106.9M | ||
| Q1 24 | $159.3M | $101.8M |
总债务CROXDOC
| Q4 25 | — | $9.8B | ||
| Q3 25 | — | $9.1B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $8.9B | ||
| Q4 24 | — | $8.7B | ||
| Q3 24 | — | $8.6B | ||
| Q2 24 | — | $8.6B | ||
| Q1 24 | — | $8.8B |
股东权益CROXDOC
| Q4 25 | $1.3B | $7.5B | ||
| Q3 25 | $1.4B | $7.6B | ||
| Q2 25 | $1.4B | $7.9B | ||
| Q1 25 | $2.0B | $8.2B | ||
| Q4 24 | $1.8B | $8.4B | ||
| Q3 24 | $1.7B | $8.6B | ||
| Q2 24 | $1.7B | $8.8B | ||
| Q1 24 | $1.6B | $8.9B |
总资产CROXDOC
| Q4 25 | $4.2B | $20.3B | ||
| Q3 25 | $4.3B | $19.6B | ||
| Q2 25 | $4.5B | $19.8B | ||
| Q1 25 | $5.1B | $19.8B | ||
| Q4 24 | $4.8B | $19.9B | ||
| Q3 24 | $4.7B | $20.0B | ||
| Q2 24 | $4.7B | $20.2B | ||
| Q1 24 | $4.8B | $20.5B |
负债/权益比CROXDOC
| Q4 25 | — | 1.31× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.14× | ||
| Q1 25 | — | 1.08× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | — | 1.00× | ||
| Q2 24 | — | 0.98× | ||
| Q1 24 | — | 0.99× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $252.5M | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $246.4M | $357.0M |
| 自由现金流率自由现金流/营收 | 25.7% | 49.6% |
| 资本支出强度资本支出/营收 | 0.6% | 124.4% |
| 现金转化率经营现金流/净利润 | 2.40× | 10.99× |
| 过去12个月自由现金流最近4个季度 | $659.2M | — |
8季度趋势，按日历期对齐
经营现金流CROXDOC
| Q4 25 | $252.5M | $1.3B | ||
| Q3 25 | $239.3M | $315.0M | ||
| Q2 25 | $285.8M | $363.5M | ||
| Q1 25 | $-67.2M | $279.4M | ||
| Q4 24 | $321.9M | $1.1B | ||
| Q3 24 | $296.9M | $318.2M | ||
| Q2 24 | $401.2M | $316.2M | ||
| Q1 24 | $-27.6M | $152.6M |
自由现金流CROXDOC
| Q4 25 | $246.4M | $357.0M | ||
| Q3 25 | $226.2M | — | ||
| Q2 25 | $269.2M | — | ||
| Q1 25 | $-82.6M | — | ||
| Q4 24 | $303.4M | $333.7M | ||
| Q3 24 | $278.8M | — | ||
| Q2 24 | $384.2M | — | ||
| Q1 24 | $-43.3M | — |
自由现金流率CROXDOC
| Q4 25 | 25.7% | 49.6% | ||
| Q3 25 | 22.7% | — | ||
| Q2 25 | 23.4% | — | ||
| Q1 25 | -8.8% | — | ||
| Q4 24 | 30.7% | 47.8% | ||
| Q3 24 | 26.3% | — | ||
| Q2 24 | 34.6% | — | ||
| Q1 24 | -4.6% | — |
资本支出强度CROXDOC
| Q4 25 | 0.6% | 124.4% | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 1.6% | — | ||
| Q4 24 | 1.9% | 105.6% | ||
| Q3 24 | 1.7% | — | ||
| Q2 24 | 1.5% | — | ||
| Q1 24 | 1.7% | — |
现金转化率CROXDOC
| Q4 25 | 2.40× | 10.99× | ||
| Q3 25 | 1.64× | — | ||
| Q2 25 | — | 11.48× | ||
| Q1 25 | -0.42× | 6.52× | ||
| Q4 24 | 0.87× | 235.43× | ||
| Q3 24 | 1.49× | 3.71× | ||
| Q2 24 | 1.75× | 2.17× | ||
| Q1 24 | -0.18× | 22.85× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CROX
| Sales Channel Directly To Consumer | $333.2M | 35% |
| Other | $332.1M | 35% |
| HEYDUDE Brand Segment | $189.3M | 20% |
| Sales Channel Through Intermediary Wholesale | $103.1M | 11% |
DOC
暂无分部数据
